(Q43539811)

24 November 2017

Progesterone modulation of D5 receptor expression in hypothalamic ANP neurons, the role of estrogen (English)

1 reference

24 November 2017

Lee D

1

1 reference

24 November 2017

Wang L

2

1 reference

24 November 2017

Dong P

3

1 reference

24 November 2017

Tran T

4

1 reference

24 November 2017

Copolov D

5

1 reference

24 November 2017

Lim AT

6

1 reference

24 November 2017

language of work or name

English

0 references

publication date

1 January 2001

1 reference

24 November 2017

1 reference

24 November 2017

6

1 reference

24 November 2017

1

1 reference

24 November 2017

112-117

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.mp.4000781

24 November 2017

0 references

cites work

Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000781

Causes and consequences of the gender difference in age at onset of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000781

Review the role of dopamine D4 receptors in schizophrenia and antipsychotic action

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000781

Dopamine receptor pharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000781

Oestrogen and progesterone interactions in the control of gonadotrophin and prolactin secretion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000781

Progesterone action in a murine Leydig tumor cell line (mLTC-1), possibly through a nonclassical receptor type

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000781

Problems and progress in the diagnosis and treatment of polydipsia and hyponatremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000781

Clozapine reduces water-drinking behavior in schizophrenic patients with polydipsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000781

Forskolin-Induced Immunoreactive Atrial Natriuretic Peptide (ANP) Secretion and Pro-ANP Messenger Ribonucleic Acid Expression of Hypothalamic Neurons in Culture: Modulation by Glucocorticoids*

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000781

Hypothalamic atrial natriuretic peptide secretion plasticity: differential modulation of alpha and beta adrenoceptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000781

Evidence for post-translational processing of auriculin B to atriopeptin III immediately prior to secretion by hypothalamic neurons in culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000781

Plasticity of adrenoceptor responsiveness on irANP secretion and pro-ANP mRNA expression in hypothalamic neuron cultures: modulation by dexamethasone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000781

Evidence for Atrial Natriuretic Peptide-(5–28) Production by Macrophages of the Rat Spleen: An Immunochemical and Nonradioactivein SituHybridization Approach*

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000781

Coexpression of atrial natriuretic factor and beta-endorphin in a subpopulation of rat splenic macrophages: age-related differences.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000781

Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNAs: genomic complexity and molecular evolution of the gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000781

Post-transcriptional regulation of glyceraldehyde-3-phosphate-dehydrogenase gene expression in rat tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000781

New Insights into the Biology of Schizophrenia through the Mechanism of Action of Clozapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000781

Oestradiol enhances the vulnerability threshold for schizophrenia in women by an early effect on dopaminergic neurotransmission. Evidence from an epidemiological study and from animal experiments

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000781

7 January 2021

A clinical trial of the effects of estrogen in acutely psychotic women

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000781

7 January 2021

Amphetamine and negative symptoms of schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000781

7 January 2021

Convergent pathways for steroid hormone- and neurotransmitter-induced rat sexual behavior

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000781

7 January 2021

Dopamine induces a biphasic modulation of hypothalamic ANF neurons: a ligand concentration-dependent effect involving D5 and D2 receptor interaction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000781

7 January 2021

Identifiers

DOI

10.1038/SJ.MP.4000781

1 reference

24 November 2017

1 reference